Die aktuelle Therapie des asbestassoziierten malignen Pleuramesothelioms – Ein Experten-Konsensuspapier

por Aigner, C., Brüning, T., Eberhardt, W. E. E., Härter, M., Kaelberlah, H.-P., Metzenmacher, M., Shah, R., Taube, C., Thomas, M.
Publicado 2021

βV-tubulin expression is associated with outcome following taxane-based chemotherapy in non-small cell lung cancer

por Christoph, D C, Kasper, S, Gauler, T C, Loesch, C, Engelhard, M, Theegarten, D, Poettgen, C, Hepp, R, Peglow, A, Loewendick, H, Welter, S, Stamatis, G, Hirsch, F R, Schuler, M, Eberhardt, W E E, Wohlschlaeger, J
Publicado 2012

1164P Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)

por Sebastian, M., Griesinger, F., von der Heyde, E., Dörfel, S., Wiegand, J.H., Schiefer, C., Losem, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Dietel, C., Bleckmann, A., Benkelmann, R., Boesche, M., Grah, C., Müller, A., Eberhardt, W.E.E., Thomas, M.
Publicado 2022

SELECT-2: a phase II, double-blind, randomized, placebo-controlled study to assess the efficacy of selumetinib plus docetaxel as a second-line treatment of patients with advanced o...

por Soria, J -C, Fülöp, A, Maciel, C, Fischer, J R, Girotto, G, Lago, S, Smit, E, Ostoros, G, Eberhardt, W E E, Lishkovska, P, Lovick, S, Mariani, G, McKeown, A, Kilgour, E, Smith, P, Bowen, K, Kohlmann, A, Carlile, D J, Jänne, P A
Publicado 2017

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

por Gore, M E, Szczylik, C, Porta, C, Bracarda, S, Bjarnason, G A, Oudard, S, Lee, S-H, Haanen, J, Castellano, D, Vrdoljak, E, Schöffski, P, Mainwaring, P, Hawkins, R E, Crinò, L, Kim, T M, Carteni, G, Eberhardt, W E E, Zhang, K, Fly, K, Matczak, E, Lechuga, M J, Hariharan, S, Bukowski, R
Publicado 2015